Vision improvement for legally blind dry macular degeneration
Part of Brain & nervous system, Eyes & vision clinical trials.
This trial tests a special optical device that may improve vision for people with legally blind dry age-related macular degeneration (AMD). It focuses on improving how well you can see, despite the damage to the center of your retina.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 50 years old.
- You have the dry type of age-related macular degeneration (AMD) — not the wet type.
- Your vision in the affected eye is 20/125 or worse, meaning you are legally blind due to AMD.
- You have a normal cornea (the clear front part of your eye) — no surgery or distortion.
- You do not wear contact lenses.
- You are willing and able to attend all study visits and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is testing whether shining a special light on the eye, called photobiomodulation, can help people with dry age-related macular degeneration (AMD). If you have dry AMD and are willing to participate, you will receive the light treatment and be monitored.
This early-stage study tests whether a stem-cell–derived transplant to the back of the eye is safe and tolerable in people with dry age-related macular degeneration (AMD). If you qualify, you may receive the transplant and have close follow-up to watch for side effects.
This study tests a new treatment to improve vision in people with advanced age-related macular degeneration (AMD). If you have significant vision loss from AMD, this might help you see better.
This study looks at how age-related macular degeneration (AMD) affects the light-sensitive part of the eye (retina) and the brain. By joining, you help researchers learn more about the condition, which could lead to better treatments in the future.
This study tests whether low-level red-light therapy can help people with dry age-related macular degeneration (AMD), a common cause of vision loss in older adults. The therapy is a painless light treatment that you might receive in multiple sessions, and the study aims to see if it can slow or improve vision decline.
This study looks at how different types of lighting (like bright or dim lights) affect your ability to see if you have dry AMD. The goal is to find lighting conditions that help you see better, which could improve your daily life.
Hear when a new Dry Age-related Macular Degeneration trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.